Ortho-Clinical Diagnostics
FDA nod triggers $30m milestone for Astute Medical
Astute Medical said it’s in line to receive up to $30 million under a standing loan agreement from funding partner CRG to commercialize its recently approved NephroCheck kidney-injury test, and could receive an additional $10 million if it hits certain revenue milestones.
Covidien names Bill Burke as CFO to lead Medtronic merger | The week in medtech M&A
Ex-Boston Scientific finance chief Capello lands at Ortho-Clinical Diagnostics
Johnson & Johnson closes Ortho-Clinical Diagnostics sale
Medtech personnel moves for the week of Mar. 10, 2014
ConMed proxy war gets ugly
February 28, 2014 by Brad Perriello
The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.
Madaus is new CEO at Carlyle’s Ortho-Clinical Diagnostics
The Carlyle Group said it tapped Martin Madaus to take over as CEO of the Ortho-Clinical Diagnostics business it’s acquiring from Johnson & Johnson (NYSE:JNJ).
